Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Journal of Inherited Metabolic Disease
Published in: Journal of Inherited Metabolic Disease 2/2015

01-03-2015 | Images in Metabolic Medicine

Look carefully to the heels! A potentially treatable cause of spastic paraplegia

Authors: Jonas Alex Saute, Roberto Giugliani, Louise S. Merkens, John (Pei-Wen) Chiang, Andrea E. DeBarber, Carolina Fischinger Moura de Souza

Published in: Journal of Inherited Metabolic Disease | Issue 2/2015

Login to get access

Abstract

ᅟ
Literature
Cali JJ, Hsieh CL, Francke U et al (1991) Mutations in the bile acid biosynthetic enzyme sterol 27-hydroxylase underlie cerebrotendinous xanthomatosis. J Biol Chem 266:7779–7783PubMed
Guyant-Maréchal L, Verrips A, Girard C et al (2005) Unusual cerebrotendinous xanthomatosis with fronto-temporal dementia phenotype. Am J Med Genet A 139:114–117CrossRef
Verrips A, Nijeholt GJ, Barkhof F et al (1999) Spinal xanthomatosis: a variant of cerebrotendinous xanthomatosis. Brain 122:1589–1595CrossRefPubMed
Metadata
Title
Look carefully to the heels! A potentially treatable cause of spastic paraplegia
Authors
Jonas Alex Saute
Roberto Giugliani
Louise S. Merkens
John (Pei-Wen) Chiang
Andrea E. DeBarber
Carolina Fischinger Moura de Souza
Publication date
01-03-2015
Publisher
Springer Netherlands
Published in
Journal of Inherited Metabolic Disease / Issue 2/2015
Print ISSN: 0141-8955
Electronic ISSN: 1573-2665
DOI
https://doi.org/10.1007/s10545-014-9745-0

Other articles of this Issue 2/2015

Journal of Inherited Metabolic Disease 2/2015 Go to the issue

Letter to the Editors

Screening for cerebrotendinous xanthomatosis

Original Article

Enzyme therapy and immune response in relation to CRIM status: the Dutch experience in classic infantile Pompe disease

Original Article

Pain: a prevalent feature in patients with mucopolysaccharidosis. Results of a cross-sectional national survey

Original Article

Barth syndrome without tetralinoleoyl cardiolipin deficiency: a possible ameliorated phenotype

Letter to the Editors

Aceruloplasminemia: neurodegeneration with brain iron accumulation (NBIA) associated with parkinsonism

Original Article

Hematopoietic cell transplantation does not prevent myelopathy in X-linked adrenoleukodystrophy: a retrospective study
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine
Image Credits